Multitargeting strategy using lenvatinib and golvatinib: Maximizing anti-angiogenesis activity in a preclinical cancer model

Almost all cancers show intrinsic and/or evasive resistance to vascular endothelial growth factor (VEGF) inhibitors by multiple mechanisms. Serum angiopoietin-2 (Ang2) level has been proposed as a potential biomarker of VEGF inhibitor response in several cancers. From these clinical observations, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakazawa, Youya, Kawano, Satoshi, Matsui, Junji, Funahashi, Yasuhiro, Tohyama, Osamu, Muto, Hiroki, Nakagawa, Takayuki, Matsushima, Tomohiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399030/
https://www.ncbi.nlm.nih.gov/pubmed/25458359
http://dx.doi.org/10.1111/cas.12581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399030/
https://www.ncbi.nlm.nih.gov/pubmed/25458359
http://dx.doi.org/10.1111/cas.12581

Ejemplares similares